Top

Published in:

01-03-2009 | Research Articles

Feasibility of adequate resectable rectal cancer treatment in a third-level hospital

Authors: Javier Gallego-Plazas, Franscisco Menárguez-Pina, Ana Maestre-Peiró, Verónica González-Orozco, Francisco Andreu, María J. Escudero-Barea, Miguel A. Morcillo

Published in: Clinical and Translational Oncology | Issue 3/2009

Title: Feasibility of adequate resectable rectal cancer treatment in a third-level hospital
Authors: Javier Gallego-Plazas
Franscisco Menárguez-Pina
Ana Maestre-Peiró
Verónica González-Orozco
Francisco Andreu
María J. Escudero-Barea
Miguel A. Morcillo
Publication date: 01-03-2009
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 3/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/S12094-009-0334-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2009

Primary non-Hodgkin lymphoma and invasive ductal carcinoma in the same breast: a rare case report

What a strange thing it is to live

Biology of BMP signalling and cancer

Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer

Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

New approaches to female fertility preservation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer